QOP
CVAC

Quinn Opportunity Partners’s CureVac CVAC Stock Holding History

Quinn Opportunity Partners’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-125,438
Closed -$676K – 381
2025
Q3 		$676K Sell
125,438
-145,473
-54% -$787K 0.05% 217
2025
Q2 		$1.47M Buy
270,911
+204,073
+305% +$809K 0.12% 157
2025
Q1 		$185K Buy
66,838
+36,838
+123% +$128K 0.01% 342
2024
Q4 		$102K Hold
30,000
– – 0.01% 355
2024
Q3 		$88.2K Hold
30,000
– – 0.01% 269
2024
Q2 		$102K Sell
30,000
-5,537
-16% -$18.1K 0.01% 253
2024
Q1 		$108K Buy
35,537
+10,000
+39% +$35.1K 0.01% 233
2023
Q4 		$108K Buy
25,537
+5,537
+28% +$30K 0.01% 216
2023
Q3 		$137K Hold
20,000
– – 0.02% 210
2023
Q2 		$208K Sell
20,000
-5,100
-20% -$45.6K 0.03% 183
2023
Q1 		$175K Buy
+25,100
New +$219K 0.02% 208

Other funds holding CVAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Quinn Opportunity Partners's CVAC Position: Q4 2025 in Review

Quinn Opportunity Partners sold out of CureVac (CVAC) in Q4 2025, closing a stake of 125,438 shares — an estimated $676K sold.

Quinn Opportunity Partners first reported a position in CVAC in Q1 2023 and held it in 11 quarters. The position peaked at $1.47M in Q2 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Quinn Opportunity Partners reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Quinn Opportunity Partners sold 125,438 CureVac shares in Q4 2025, an estimated $676K.
  • Quinn Opportunity Partners first reported a position in CureVac in Q1 2023 and held it in 11 quarters.
  • Quinn Opportunity Partners's CureVac position peaked at $1.47M in Q2 2025.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Quinn Opportunity Partners's 13F filing for Q4 2025, filed 13 Feb 2026.